{
    "doi": "https://doi.org/10.1182/blood.V104.11.1364.1364",
    "start_url": "https://ashpublications.org/blood/search-results?sort=Date+-+Oldest+First&f_ArticleTypeDisplayName=Meeting+Report&fl_SiteID=1000001&page=20",
    "start_url_page_num": 20,
    "is_scraped": "1",
    "article_title": "Glutathione-S-Transferase \u03c0 Expression Helps for Differential Diagnosis between Mantle Cell Lymphoma and Marginal Zone Lymphoma with t(11;14). ",
    "article_date": "November 16, 2004",
    "session_type": "Poster Sessions",
    "abstract_text": "Glutathione-S-transferase \u03c0 (GST\u03c0), whose gene is located in 11q13, is belonging to a complex multigene family of enzymes that may detoxify electrophilic xenobiotics. Recent gene expression profiling analysis showed that GST\u03c0 transcript is belonging to the mantle cell lymphoma (MCL) signature and constitutes one of the most expressed mRNA in MCL * . Furthermore it has been reported by immunohistochemistry that overexpression of cyclin D1 in MCL was associated with a high level of GST\u03c0 protein expression. We then looked for the specificity of a high level of GST\u03c0 protein expression in MCL, and particularly when comparing to marginal zone lymphoma (MZL) with t(11;14). Material and Methods: Immunochemistry analysis of GST\u03c0 and cyclinD1 expression was performed 111 non Hodgkin\u2019s lymphoma including MCL, MZL, small lymphocytic lymphoma (SLL), follicular lymphoma (FL), and diffuse large B-cell lymphoma (DLBCL) cases with or without t(11;14). Results: A strong GST\u03c0 expression in more than 50% of the cells was observed in 98% of the MCL. None of the MZL cases with t(11;14) expressed GST\u03c0, except one case that expressed a weak signal in less than 20% of the cells. None of the MZL without t(11;14) expressed GSTpi. Only two (13%) FL graded 3 according to OMS classification expressed GST\u03c0 in less than 50% of the cells. A high GST\u03c0 expression (>50% cells stained) was detected in 29% of the DLBCL and 43% of the SLL. * C. Thieblemont et al. Non-germinal B-cell lymphoma exhibit distinct genomic profiles allowing molecular diagnosis. Blood  2004 ; 103 : 2727 \u20132737  . n . GST \u03c0 expression >50% . GST \u03c0 expression 5\u201350% . \u03c0 GST expression <5% . MCL with t(11;14) 25 23 0 2 MZL with t(11;14) 5 0 1(weak) 4 MZL without t(11;14) 31 0 1 (weak) 30 FL without t(11;14) 15 0 2 13 DLBCL without t(11;14) 14 4 1 9 SLL without t(11;14) 21 6 3 12 . n . GST \u03c0 expression >50% . GST \u03c0 expression 5\u201350% . \u03c0 GST expression <5% . MCL with t(11;14) 25 23 0 2 MZL with t(11;14) 5 0 1(weak) 4 MZL without t(11;14) 31 0 1 (weak) 30 FL without t(11;14) 15 0 2 13 DLBCL without t(11;14) 14 4 1 9 SLL without t(11;14) 21 6 3 12 View Large In conclusion, 98% of the MCL with t(11;14) expressed high level of GST\u03c0 whereas none of our MZL with t(11;14) and high transcriptional cyclinD1 expression expressed GST\u03c0. This results may help for differential diagnosis between MCL and MZL with t(11;14) and suggest different transcriptional regulation of GST\u03c0 in lymphoma subtypes with t(11;14), contributing possibly to the chemoresistant phenotype of MCL. Finally, this confirmed our previous work on MZL with t(11;14).",
    "topics": [
        "glutathione s-transferase",
        "mantle-cell lymphoma",
        "marginal zone b-cell lymphoma",
        "diffuse large b-cell lymphoma",
        "small cell lymphoma",
        "lymphoma",
        "cyclin d1",
        "enzymes",
        "follicular lymphoma",
        "gene expression profiling"
    ],
    "author_names": [
        "D. Rolland",
        "S. Gazzo",
        "P. Felman",
        "E. Callet-Bauchu",
        "A. Traverse-Glehen",
        "L. Baseggio",
        "A. Paret",
        "F. Chapuis",
        "G. Salles",
        "B. Coiffier",
        "F. Berger",
        "C. Thieblemont"
    ],
    "author_affiliations": [
        [
            "Service Hematologie clinique et biologique, Centre Hospitalier Lyon-sud, France"
        ],
        [
            "Service Hematologie clinique et biologique, Centre Hospitalier Lyon-sud, France"
        ],
        [
            "Service Hematologie clinique et biologique, Centre Hospitalier Lyon-sud, France"
        ],
        [
            "Service Hematologie clinique et biologique, Centre Hospitalier Lyon-sud, France"
        ],
        [
            "Service Anatomo-Pathologie, Centre Hospitalier Lyon-sud, France"
        ],
        [
            "Service Hematologie clinique et biologique, Centre Hospitalier Lyon-sud, France"
        ],
        [
            "Service Hematologie clinique et biologique, Centre Hospitalier Lyon-sud, France"
        ],
        [
            "FHARE, Hospices civils de Lyon, France"
        ],
        [
            "Service Hematologie clinique et biologique, Centre Hospitalier Lyon-sud, France"
        ],
        [
            "Service Hematologie clinique et biologique, Centre Hospitalier Lyon-sud, France"
        ],
        [
            "Service Anatomo-Pathologie, Centre Hospitalier Lyon-sud, France"
        ],
        [
            "Service Hematologie clinique et biologique, Centre Hospitalier Lyon-sud, France"
        ]
    ],
    "first_author_latitude": "45.702775599999995",
    "first_author_longitude": "4.804545300000001"
}